Intellia Therapeutics
Dylan Bordeaux is an experienced Process Development Engineer with a strong background in the pharmaceutical industry. Currently serving as a Process Development Engineer III at Intellia Therapeutics, Inc., since April 2021, Dylan has advanced from previous roles as a Process Development Engineer II and a Process Engineer at AMRI, where responsibilities included tech transfer, process design, and GMP production optimization. Key accomplishments include the development of formulation processes for liposomes and the management of quality assurance functions to address GMP compliance. Dylan's earlier experience includes a role as a Regulatory and R&D Intern at Foster Corporation, where responsibilities encompassed test sample preparation and data collection under GMP regulations. Educational qualifications include a Master of Engineering in Chemical Engineering and a Bachelor's degree in the same field from the University of Massachusetts Lowell.
This person is not in any teams
This person is not in any offices
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.